Literature DB >> 28940255

The Eutos long-term survival score accurately predicts the risk of death in chronic myeloid leukaemia patients treated outside of clinical trials.

Matteo Molica1, Martina Canichella1, Danilo Alunni Fegatelli1, Gioia Colafigli1, Fulvio Massaro1, Roberto Latagliata1, Robin Foà1, Massimo Breccia1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28940255     DOI： 10.1002/ajh.24913

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

Review 1.  Early Management of CML.

Authors:  Naranie Shanmuganathan; Timothy P Hughes
Journal:  Curr Hematol Malig Rep       Date:  2019-12       Impact factor: 3.952

2.  The EUTOS long-term survival score predicts disease-specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice-based cohort.

Authors:  Eriko Sato; Noriyoshi Iriyama; Michihide Tokuhira; Tomoiku Takaku; Maho Ishikawa; Tomonori Nakazato; Kei-Ji Sugimoto; Hiroyuki Fujita; Yuta Kimura; Isao Fujioka; Norio Asou; Norio Komatsu; Masahiro Kizaki; Yoshihiro Hatta; Tatsuya Kawaguchi
Journal:  Cancer Med       Date:  2020-10-10       Impact factor: 4.452

3.  A Retrospective Cohort Study of Upfront Nilotinib in Chronic Myeloid Leukemia: A Single-Center Experience.

Authors:  Reema Singh; Jyotsna Kapoor; Rayaz Ahmed; Pallavi Mehta; Vishvdeep Khushoo; Pragya Agrawal; Dinesh Bhurani; Narendra Agrawal
Journal:  South Asian J Cancer       Date:  2021-11-24

4.  Validation of the EUTOS Long-Term Survival Score in Chinese Chronic Myeloid Leukemia Patients Treated with Imatinib: A Multicenter Real-World Study.

Authors:  Xiawan Yang; Yanliang Bai; Mingyue Shi; Wanjun Zhang; Junwei Niu; Chengye Wu; Lei Zhang; Zhiwei Xu; Xiang Liu; Yuqing Chen; Kai Sun
Journal:  Cancer Manag Res       Date:  2020-02-20       Impact factor: 3.989
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.